A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/1997
10/02/1997	WO1997035855A1 Novel treatment for cns injuries
10/02/1997	WO1997035854A1 Novel phenanthridines substituted in the 6 position
10/02/1997	WO1997035852A1 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
10/02/1997	WO1997035849A1 1,2,4-triazine derivatives for the inhibition of protein glycosylation
10/02/1997	WO1997035619A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
10/02/1997	WO1997035606A1 Macrophage stimulating protein for the treatment of gastrointestinal disorders
10/02/1997	WO1997035601A1 TREATMENT OF CYSTIC DISEASE WITH TNF-$g(a)
10/02/1997	WO1997035595A1 Egg anti-inflammatory composition, method of isolation and use
10/02/1997	WO1997035581A1 Interleukin-6 production inhibitor
10/02/1997	WO1997035578A1 Tetrahydro-beta-carboline compounds
10/02/1997	WO1997035575A1 Use of rapamycin derivatives in vasculopathies and xenotransplantation
10/02/1997	WO1997035572A1 Carboxylic acid indole inhibitors of chemokines
10/02/1997	WO1997035567A1 Pla2 inhibitors of angiogenesis
10/02/1997	WO1997035556A1 Use of an extract of at least one iridaceous plant for treating wrinkles
10/02/1997	WO1997035539A2 Arylamino fused pyridines and pyrimidines
10/02/1997	WO1997035538A2 Tumor necrosis factor alpha convertase
10/02/1997	WO1997035491A1 Agent for increasing the production of/in breeding and production mammals
10/02/1997	WO1997035480A1 Method of treating common cold or allergic rhinitis
10/02/1997	WO1997035479A1 Methods of treating venomous bites and stings
10/02/1997	WO1997026331A3 Use of neuronal apoptosis inhibitor protein (naip)
10/02/1997	DE19612645A1 Dimethyl-substituierte Cyclohexandienderivate Dimethyl-substituted Cyclohexandienderivate
10/02/1997	DE19612463A1 Neues Protein mit differenzierungsinduzierender Aktivität für erythropoetische Zellen Novel protein differenzierungsinduzierender activity for erythropoietic cells
10/02/1997	CA2251691A1 Peptides with antiproliferative properties
10/02/1997	CA2250576A1 Monocyte chemotactic protein-5 materials and methods
10/02/1997	CA2250459A1 Methods of treating venomous bites and stings
10/02/1997	CA2250403A1 Treatment of cystic disease with tnf-a
10/02/1997	CA2250241A1 Arylamino fused pyridines and pyrimidines
10/02/1997	CA2250207A1 A novel mammalian gene, bcl-w, belongs to the bcl-2 family of apoptosis-controlling genes
10/02/1997	CA2249999A1 1,2,4-triazine derivatives for the inhibition of protein glycosylation
10/02/1997	CA2249985A1 Tumour necrosis factor alpha convertase
10/02/1997	CA2249652A1 Method of treating common cold or allergic rhinitis
10/02/1997	CA2249455A1 Precursors of catalytic antibodies
10/02/1997	CA2249354A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
10/02/1997	CA2249254A1 Epidermal differentiation factor
10/02/1997	CA2248874A1 Tetrahydro-beta-carboline compounds
10/02/1997	CA2248318A1 Growth factor htter36
10/01/1997	EP0798001A2 Collagen containing preparations for strengthening bone
10/01/1997	EP0797997A2 Use of bradykinin antagonists for the preparation of medicaments
10/01/1997	EP0797995A2 Use of a 5-HT2 receptor antagonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis
10/01/1997	EP0797994A2 Use of one or more 5-HT2 receptor antagonists in the manufacture of a medicament for treating the symptoms of venomous bites and stings
10/01/1997	EP0797993A1 Compostions comprising l-carnitine or derivatives thereof and antioxidants
10/01/1997	EP0797990A2 Use of steroid antagonists for the treatment and prophylaxis of dementia-related disorders
10/01/1997	EP0797989A1 Solid pharmaceutical composition comprising leflunomid
10/01/1997	EP0797985A1 Use of an extract of iridaceas in the treatment of skin wrinkles
10/01/1997	EP0797984A2 Anti-aging cosmetic composition
10/01/1997	EP0797678A2 Hybrid adenovirus-aav virus and method of use thereof
10/01/1997	EP0797664A1 Human interleukin-11 receptor
10/01/1997	EP0797663A1 Sox-9 gene and protein and use in the regeneration of bone or cartilage
10/01/1997	EP0797592A1 Human stanniocalcin-alpha
10/01/1997	EP0797591A1 A novel chemokine expressed in inflamed adenoid, its production and uses
10/01/1997	EP0797590A1 Neurotrophic peptides of activity dependent neurotrophic factor
10/01/1997	EP0797581A1 Novel protein tyrosine kinase, jak3
10/01/1997	EP0797575A1 Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase
10/01/1997	EP0797446A1 Cd40 associated proteins
10/01/1997	EP0797444A1 Kit for osteoporosis treatment cycle
10/01/1997	EP0797443A1 A pharmaceutical composition with improved bio-availability of inositol phosphate
10/01/1997	EP0797437A1 IMMUNOTHERAPEUTIC IMIDES/AMIDES AND THEIR USE FOR REDUCING LEVELS OF TNF$g(a)
10/01/1997	EP0797427A1 Agents acting against hyperreactive and hypoactive, deficient skin conditions and manifest dermatitides
10/01/1997	CN1161041A Heterocycle-condensed morphinoid derivatives
10/01/1997	CN1161040A Bicyclic tetrahydro pyrazolopyridines and their use as medicaments
10/01/1997	CN1160998A Method of inhibiting conditions associated with neuropeptide Y
10/01/1997	CN1160716A New compounds derived from boronic acid, process for their preparation and pharmaceutical compositions containing them
10/01/1997	CN1160579A Chinese herbal medicine capsule for curing saccular mastoproliferation
10/01/1997	CN1160564A Tonic wine
10/01/1997	CN1036003C A process for preparing (1H-azol-1-ylmethyl) substituted quinazoline derivatives
10/01/1997	CN1036002C A process for preparing (1H-azol-1-ylmethyl) substituted quinazoline derivatives
09/1997
09/30/1997	US5672709 Heterocyclic compounds and their preparation and use
09/30/1997	US5672693 Lipopolysaccharides a cell membrane extract from gramnegative bacteria used as b cell activators
09/30/1997	US5672620 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
09/30/1997	US5672618 Protein kinase C inhibitors
09/30/1997	US5672611 Antitumor agents, farnesyl protein transferase enzyme inhibitors
09/30/1997	US5672610 Therapy for immunosuppression
09/30/1997	US5672602 Substituted piperazine derivatives
09/30/1997	US5672599 Compounds containing a fused bicycle ring
09/30/1997	US5672598 Matrix metalloprotease inhibitors
09/30/1997	US5672596 Animal growth controllers
09/30/1997	US5672587 Isoproterenol prodrug with reduced side effects
09/30/1997	US5672583 Carboxy-peptidyl derivatives as antidegenerative active agents
09/30/1997	US5672582 Anticoagulants; 4-substituted cyclohexylamine derivatives
09/30/1997	US5672508 Polypeptide comprising cyclin dependent kinase binding motifs from two or more proteins
09/30/1997	US5672500 Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same
09/30/1997	US5672356 Bioadhesive pharmaceutical composition for the controlled release of active principles
09/30/1997	US5672336 Process of preparing microparticulate collagen, collagen-based products thereby and method of applying same
09/29/1997	CA2200267A1 Novel sphingolipids and a process thereto
09/27/1997	CA2201088A1 Use of .alpha.1 -adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
09/27/1997	CA2201040A1 Solid pharmaceutical preparation, comprising 5-methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide
09/27/1997	CA2200040A1 Use of bradykinin antagonists for the production of pharmaceuticals for the treatment of chronic fibrogenetic liver disorders and acute liver disorders
09/25/1997	WO1997035019A1 Protein tyrosine phosphatases of hematopoietic cells
09/25/1997	WO1997035015A2 Tyrosine-phosphatase-related protein
09/25/1997	WO1997035014A1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF IλB$g(a)
09/25/1997	WO1997035010A1 Chemokine alpha 2
09/25/1997	WO1997035002A1 Purification of pharmaceutical-grade plasmid dna
09/25/1997	WO1997034901A1 Piperidine derivatives
09/25/1997	WO1997034900A1 Azaspiro derivatives
09/25/1997	WO1997034897A1 Fused imidazole derivatives as multidrug resistance modulators
09/25/1997	WO1997034895A1 Novel n-7-heterocyclyl pyrrolo[2,3-d]pyridines and their use
09/25/1997	WO1997034887A1 NOVEL ASYMMETRIC SYNTHESIS OF R-α-PROPYL-PIPERONYL AMINE AND ITS ANALOGS
09/25/1997	WO1997034885A1 Benzopyran derivatives having leukotriene-antagonistic action
09/25/1997	WO1997034883A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
09/25/1997	WO1997034633A1 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith

1 ... 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 ... 1564